In a failed attempt to explain away why vaccinated individuals seem to be the only ones contracting and spreading whooping cough during major outbreaks, the U.S. Food and Drug Administration (FDA) recently launched an inquiry aimed at better understanding how the controversial vaccine works. But what the agency ended up discovering is that the vaccine for whooping cough, also known as pertussis, spreads the very same pathogenic bacteria that causes whopping cough in the first place, which in some people can lead to serious infections.
Published in the Proceedings of the National Academy of Sciences, the new FDA study claims to demonstrate that vaccines for acellular pertussis are effective at preventing the disease in those who are vaccinated. But at the very same time, the agency admits that, based on its findings, the vaccine itself spreads Bordetella pertussis, the bacteria responsible for triggering the highly contagious respiratory disease.
“[A]cellular pertussis vaccines licensed by the FDA are effective in preventing the disease among those vaccinated,” claims the agency in a recent announcement, “but… they may not prevent infection from the bacteria that causes whooping cough in those vaccinated or its spread to other people, including those who may not be vaccinated.”
In other words, the whooping cough vaccine is definitely effective at preventing the whooping cough, except that it’s not. This is the essence of what the FDA is claiming here with this dichotomy — people who are vaccinated for whooping cough are somehow protected against the disease, but they might still develop it as a result of contracting the bacterium responsible for triggering whooping cough, which is contained in the vaccine.
This type of meaningless equivocation is nothing new for the FDA, of course, which two years ago tried to pull the same
say-something-while-not-actually-saying-it stunt with bisphenol A
(BPA), the plastics chemical that has repeatedly been shown in scientific literature to damage hormones.
FDA admits whooping cough vaccines diminish immunity, increasing likelihood of infection
Besides putting those who receive it at a higher risk of developing pertussis infection, the pertussis vaccine also admittedly lowers immunity. In a recent press release about its study, the FDA spills the beans about how decreased immunity is a common adverse effect of the childhood pertussis vaccine, and that health experts have never really understood why those who are vaccinated against pertussisstill contract the disease.
“While the reasons for the increase in cases of whooping cough are not fully understood, multiple factors are likely involved, including diminished immunity from childhood pertussis vaccines, improved diagnostic testing, and increased reporting,” says the FDA. “With its own funds plus support from the National Institutes of Health (NIH), the FDA conducted the study to explore the possibility that acellular pertussis vaccines… might not prevent infection.”
Based on this assessment, it is astounding that any parent would ever agree to having their baby injected with a chemical solution that just might cause the very same disease that it is supposed to prevent. We now know for a fact that children vaccinated for pertussis can still develop whooping cough and are, in fact, carriers that can spread the disease to others.
“This research suggests that although individuals immunized with an acellular pertussis vaccine may[emphasis added] be protected from disease, they may still become infected with the bacteria without always getting sick and are able to spread infection to others, including young infants who are susceptible to pertussis disease.”
You can read the full FDA announcement here:
Sources for this article include: